Image-guided Therapy Systems Market Size, Share, Growth, and Industry Analysis, By Type ( Computed Tomography (CT) Scanners, Ultrasound Systems, Magnetic Resonance Imaging (MRI), Endoscope, X-ray Fluoroscopy, Positron Emission Tomography (PET), Single Photon Emission Computed Tomography (SPECT) ), By Application ( Cardiac Surgery, Neurosurgery, Orthopedic Surgery, Urology, Gastroenterology, Oncology Surgery, Others ), Regional Insights and Forecast to 2035

Image-guided Therapy Systems Market Overview

Global Image-guided Therapy Systems Market size is projected at USD 3083.95 million in 2026 and is expected to hit USD 4363.91 million by 2035 with a CAGR of 3.6%.

The image-guided therapy systems market is expanding steadily due to the rising volume of minimally invasive procedures, which reached over 25 million procedures globally in 2024. Imaging modalities such as CT, MRI, and ultrasound are integrated into surgical workflows, with over 68% of tertiary hospitals adopting hybrid operating rooms. Approximately 57% of complex surgeries now involve some form of real-time imaging assistance. Technological penetration has increased with over 42% of new installations featuring AI-enabled navigation systems. The growing aging population, accounting for 12% of the global population above age 65, continues to drive demand for precision-based interventional procedures.

In the United States, more than 7.5 million image-guided procedures were performed in 2024, accounting for nearly 29% of global procedural volume. Around 74% of hospitals with more than 200 beds have installed at least one advanced imaging-guided therapy system. MRI-guided interventions represent 21% of total usage, while CT-guided systems dominate with 38% utilization. The U.S. healthcare system reports that over 63% of oncological surgeries now incorporate real-time imaging for improved precision. Adoption of hybrid operating rooms has increased by 46% in the last five years, while robotic-assisted imaging procedures have reached a penetration rate of 18% across major hospitals.

Download Free Sample to learn more about this report.

Key Findings

• Key Market Driver: Rising minimally invasive procedures account for 68% adoption globally.
• Major Market Restraint: High installation costs impact nearly 49% of healthcare facilities.
• Emerging Trends: AI integration in imaging systems has reached 44% penetration.
• Regional Leadership: North America leads the market with a 39% share.
• Competitive Landscape: Top players collectively hold around 61% market share.
• Market Segmentation: CT scanners dominate with approximately 38% share.
• Recent Development: AI-focused product innovations represent about 41% of new launches.

Image-guided Therapy Systems Market Latest Trends

The image-guided therapy systems market is witnessing strong innovation driven by technological advancements and increasing clinical demand. AI-powered imaging systems have reached adoption levels of 44%, enabling automated diagnostics and real-time image enhancement. Hybrid operating rooms are now installed in 52% of advanced healthcare facilities, integrating multiple imaging modalities for seamless surgical workflows. Robotic-assisted interventions have expanded to 18% of procedures, enhancing precision in complex surgeries such as neurosurgery and oncology. Portable imaging systems are gaining traction, with 29% of hospitals adopting compact ultrasound and mobile CT units to improve accessibility. High-resolution imaging systems offering sub-millimeter accuracy are used in 63% of advanced surgical centers, improving diagnostic clarity.

The integration of 3D imaging technology has increased by 36%, allowing surgeons to visualize anatomical structures more effectively. Additionally, cloud-based imaging platforms are utilized by 31% of healthcare providers for data storage and remote consultation. Patient-centric approaches are also influencing market trends, with 47% of healthcare institutions focusing on reducing procedure time and improving recovery outcomes. Radiation dose reduction technologies have improved safety, with exposure levels decreasing by 28% compared to conventional imaging systems. The increasing prevalence of chronic diseases, affecting 60% of adults globally, further drives demand for accurate and minimally invasive treatment options supported by advanced imaging systems.

Image-guided Therapy Systems Market Dynamics

DRIVER

"Rising demand for minimally invasive procedures."

The demand for minimally invasive procedures has increased significantly, with over 68% of surgeries now performed using image-guided techniques. These procedures reduce recovery time by 32% and lower post-operative complications by 35%. The global rise in chronic diseases, affecting approximately 60% of adults, has increased the need for precise diagnostic and treatment methods. Imaging systems enable real-time visualization, improving surgical accuracy by 41%. Hospitals adopting advanced imaging technologies have reported a 27% reduction in patient hospitalization duration. Additionally, the aging population, which represents 12% of the global demographic, is more prone to conditions requiring image-guided interventions, further accelerating market demand.

RESTRAINT

"High cost of advanced imaging systems."

The cost of installing advanced imaging systems remains a significant barrier, with initial setup expenses impacting 49% of healthcare institutions. Maintenance costs account for 18% of total operational expenses, while software upgrades contribute an additional 12%. Smaller hospitals and clinics face adoption challenges, with 37% reporting budget constraints. Training requirements also limit usage, as 31% of healthcare professionals require specialized training for system operation. In developing regions, only 24% of hospitals have access to advanced imaging systems due to financial limitations. Additionally, reimbursement issues affect 22% of facilities, slowing down investment in high-end imaging technologies.

OPPORTUNITY

"Growth in AI and robotic-assisted imaging."

The integration of AI and robotics presents significant growth opportunities, with AI adoption reaching 44% in imaging systems. Robotic-assisted procedures have increased by 18%, improving surgical precision and reducing human error by 29%. Predictive analytics in imaging systems enhances diagnostic accuracy by 33%, enabling early disease detection. Emerging markets are witnessing rapid adoption, with healthcare infrastructure investments increasing by 36%. Portable imaging systems are also gaining traction, with 29% growth in adoption due to their cost-effectiveness and accessibility. Telemedicine integration allows 21% of imaging procedures to be remotely analyzed, expanding healthcare reach in underserved areas.

CHALLENGE

"Technical complexity and data management issues."

The complexity of image-guided systems poses operational challenges, with 34% of healthcare facilities reporting integration difficulties. Data management is another critical issue, as imaging systems generate over 500 gigabytes of data per patient annually in advanced procedures. Cybersecurity concerns affect 27% of institutions due to the increasing use of cloud-based platforms. Interoperability issues between different imaging systems impact 22% of hospitals, limiting workflow efficiency. Additionally, system downtime and maintenance delays contribute to a 15% reduction in operational efficiency. Addressing these challenges requires significant investment in IT infrastructure and skilled personnel, which remains a constraint for many healthcare providers.

Image-guided Therapy Systems Market Segmentation

Download Free Sample to learn more about this report.

By Type

Computed Tomography (CT) Scanners: Computed tomography systems remain the backbone of image-guided therapy due to their strong integration into interventional radiology and oncology workflows. These systems are widely preferred for procedures requiring rapid imaging and precise anatomical visualization, especially in trauma and emergency care settings. CT scanners hold approximately 38% share, reflecting their dominant role in hospitals and advanced diagnostic centers. Their ability to provide cross-sectional imaging enhances surgical navigation and improves procedural planning. Hospitals increasingly rely on CT guidance for biopsies, tumor ablation, and vascular interventions. Modern CT platforms are designed with enhanced detector sensitivity, allowing clinicians to achieve imaging clarity while maintaining patient safety. Low-dose imaging protocols have significantly improved patient outcomes by minimizing radiation exposure, with reductions reaching nearly 28% compared to earlier systems.

Ultrasound Systems: Ultrasound systems are gaining prominence in image-guided therapy due to their portability, safety, and cost-effectiveness. These systems are widely used across primary care, emergency departments, and outpatient settings, enabling real-time imaging without exposure to ionizing radiation. Ultrasound holds around 18% market share, driven by its versatility in multiple clinical applications such as obstetrics, cardiology, and urology. One of the major advantages of ultrasound is its ability to provide live imaging, which is critical for guiding needle-based procedures and fluid drainage interventions. Portable ultrasound devices are increasingly being deployed in rural and remote areas, enhancing healthcare accessibility. These systems are now used in over 71% of primary healthcare facilities, demonstrating their widespread adoption. Technological advancements have improved image resolution and penetration depth, making ultrasound suitable for more complex procedures.

Magnetic Resonance Imaging (MRI): Magnetic resonance imaging systems play a crucial role in high-precision image-guided therapy, particularly in neurology and oncology applications. MRI systems are known for their superior soft tissue contrast, making them ideal for detecting abnormalities that are not visible through other imaging modalities. These systems account for approximately 22% market share, reflecting their importance in specialized medical procedures. MRI-guided interventions are increasingly used in brain surgeries and tumor treatments, where precision is critical. The ability to provide detailed imaging without radiation exposure is a key advantage, especially for patients requiring repeated scans. Advanced MRI systems equipped with higher magnetic field strengths offer improved image clarity and faster scanning times. Around 48% of neurological procedures now utilize MRI guidance, indicating its growing relevance in complex surgeries.

Endoscope: Endoscopic imaging systems are widely used in minimally invasive procedures, particularly in gastrointestinal and respiratory applications. These systems provide direct visualization of internal organs, enabling clinicians to diagnose and treat conditions with minimal patient discomfort. Endoscopes account for around 9% of the market, reflecting their specialized yet essential role in medical procedures. The use of high-definition imaging has significantly improved the quality of visualization, allowing for better detection of abnormalities. Endoscopic procedures are now used in over 67% of gastrointestinal interventions, highlighting their importance in digestive health management. Flexible endoscopes have become increasingly popular due to their ability to navigate complex anatomical pathways. These systems are also used in surgical procedures such as laparoscopy, where small incisions are preferred over open surgery. Advances in imaging technology have enabled the development of ultra-thin and high-resolution endoscopes, improving patient outcomes.

X-ray Fluoroscopy: X-ray fluoroscopy systems are essential for real-time imaging during interventional procedures, particularly in cardiology and orthopedics. These systems allow clinicians to observe dynamic processes within the body, enabling precise guidance during surgeries and diagnostic procedures. Fluoroscopy holds approximately 7% market share, reflecting its niche yet critical role in specific medical applications. It is widely used in procedures such as angioplasty, where accurate visualization of blood vessels is required. Over 52% of angioplasty procedures rely on fluoroscopic guidance, demonstrating its importance in cardiovascular care. Modern fluoroscopy systems are equipped with advanced imaging technologies that improve image quality while reducing radiation exposure. Radiation safety has improved significantly, with reductions of up to 26% achieved through advanced dose management techniques. These systems also support digital imaging and storage, allowing for better documentation and analysis of procedures.

Positron Emission Tomography (PET): Positron emission tomography systems are primarily used for functional imaging, providing insights into metabolic activity within the body. These systems are particularly valuable in oncology, where they help in detecting cancer and monitoring treatment response. PET systems hold around 4% market share, reflecting their specialized use in advanced diagnostic procedures. They are often combined with CT or MRI to provide both structural and functional imaging. Approximately 63% of cancer diagnostics utilize PET imaging, highlighting its importance in oncology care. PET systems enable early detection of diseases, improving treatment outcomes and patient survival rates. The use of hybrid imaging systems has enhanced diagnostic accuracy, allowing clinicians to make more informed decisions. Advances in imaging technology have also reduced scanning time and improved patient comfort.

Single Photon Emission Computed Tomography (SPECT): SPECT systems are used for functional imaging, particularly in cardiac and neurological applications. These systems provide three-dimensional images that help in assessing organ function and blood flow. SPECT holds approximately 2% market share, reflecting its specialized role in diagnostic imaging. It is widely used in cardiac imaging, with over 41% of procedures relying on this technology to evaluate heart function. SPECT systems are often combined with CT to improve diagnostic accuracy and provide comprehensive imaging data. These hybrid systems enhance the ability to detect abnormalities and guide treatment decisions. Advances in detector technology have improved image resolution and reduced scanning time. SPECT is also used in neurology to study brain disorders and monitor disease progression. The integration of digital imaging and data analysis tools has further enhanced its capabilities.

By Application

Cardiac Surgery: Cardiac surgery represents a significant application area for image-guided therapy systems, driven by the increasing prevalence of cardiovascular diseases worldwide. Imaging technologies play a critical role in procedures such as angioplasty, valve repair, and coronary artery bypass surgery. This segment accounts for approximately 19% of total applications, reflecting its importance in clinical practice. Image-guided systems enable precise visualization of blood vessels and cardiac structures, improving surgical outcomes. Over 2.3 million procedures are performed annually using imaging guidance, highlighting strong demand. These systems reduce complications and enhance procedural accuracy, making them essential in modern cardiac care. Advances in imaging technology have also enabled minimally invasive cardiac procedures, reducing recovery time for patients. Integration with robotic systems further enhances precision and control during surgery. As the global burden of heart disease continues to rise, the demand for image-guided cardiac interventions is expected to grow steadily.

Neurosurgery: Neurosurgery relies heavily on image-guided systems for accurate diagnosis and treatment of brain and spinal conditions. These systems provide detailed imaging of neural structures, enabling surgeons to perform complex procedures with high precision. Neurosurgery accounts for around 14% of applications, reflecting its specialized nature. MRI is widely used in this field, supporting nearly 48% of procedures due to its superior imaging capabilities. Image-guided systems improve tumor resection accuracy and reduce the risk of damage to surrounding tissues. These technologies also support minimally invasive procedures, improving patient outcomes and reducing recovery time. Continuous advancements in imaging and navigation systems are enhancing the capabilities of neurosurgery.

Orthopedic Surgery: Orthopedic surgery utilizes image-guided systems to improve accuracy in procedures involving bones and joints. These systems are essential for joint replacement, fracture repair, and spinal surgeries. Orthopedic applications account for approximately 13% of the market, reflecting their widespread use. Imaging guidance is used in over 52% of joint replacement procedures, improving alignment and positioning. These systems enhance surgical precision and reduce the risk of complications. Advances in imaging technology have also enabled minimally invasive orthopedic procedures, improving patient recovery. Integration with navigation systems allows for better planning and execution of surgeries. As the aging population increases, the demand for orthopedic procedures is expected to grow.

Urology: Urology applications benefit from image-guided systems in procedures such as kidney stone removal and prostate treatment. These systems provide real-time imaging, enabling accurate targeting and treatment. Urology accounts for around 9% of applications, reflecting its specialized role. Ultrasound is widely used in this field, supporting nearly 61% of procedures. Image-guided systems improve treatment outcomes and reduce complications. Advances in imaging technology have also enabled minimally invasive procedures, improving patient comfort. As the prevalence of urological conditions increases, the demand for these systems is expected to rise.

Gastroenterology: Gastroenterology relies on image-guided systems for diagnosing and treating digestive disorders. Endoscopic imaging is widely used in this field, providing direct visualization of the gastrointestinal tract. This segment accounts for approximately 11% of applications, reflecting its importance. Endoscopic procedures are used in over 67% of cases, improving diagnostic accuracy. These systems enable minimally invasive procedures, reducing patient discomfort and recovery time. Advances in imaging technology have improved visualization and treatment capabilities. As the prevalence of digestive disorders increases, the demand for image-guided systems in gastroenterology is expected to grow.

Oncology Surgery: Oncology surgery is the largest application segment, accounting for approximately 26% of the market. Image-guided systems are essential for detecting and treating cancer, enabling precise tumor localization and removal. These systems are used in over 63% of cancer procedures, highlighting their importance. Imaging technologies improve surgical accuracy and reduce the risk of recurrence. Advances in imaging and navigation systems are enhancing treatment outcomes. As cancer incidence continues to rise globally, the demand for image-guided oncology procedures is expected to increase.

Others: Other applications include ENT, vascular, and pulmonary procedures, which collectively account for approximately 8% of the market. Image-guided systems are used in over 44% of these procedures, improving diagnostic and treatment accuracy. These systems enable minimally invasive interventions, reducing patient recovery time. Advances in imaging technology are expanding their use across various medical fields. As healthcare systems continue to adopt advanced technologies, the demand for image-guided systems in these applications is expected to grow.

Image-guided Therapy Systems Market Regional Outlook

Download Free Sample to learn more about this report.

North America

North America remains the leading region in the image-guided therapy systems market due to its advanced healthcare infrastructure and high adoption of innovative technologies. The region accounts for approximately 39% of the global market, supported by strong hospital networks and research institutions. A significant number of hospitals have integrated imaging systems into surgical workflows, improving procedural efficiency. The region performs more than 8 million minimally invasive procedures annually, highlighting the growing demand for precision-based healthcare solutions. Advanced imaging technologies are widely used in oncology, cardiology, and neurology, supporting accurate diagnosis and treatment. The adoption of AI-enabled imaging systems has increased significantly, enhancing diagnostic capabilities. The presence of leading manufacturers and continuous investment in healthcare infrastructure further drive market growth.

Europe

Europe holds a significant share in the image-guided therapy systems market, accounting for approximately 28% of the global market. The region benefits from well-established healthcare systems and strong government support for medical technology adoption. A large number of hospitals have implemented advanced imaging systems, improving diagnostic and treatment capabilities. Europe performs over 6 million procedures annually, reflecting strong demand for minimally invasive interventions. MRI and CT systems are widely used, supporting a broad range of clinical applications. Government initiatives and funding programs have increased healthcare investments, enhancing access to advanced technologies. The region also has a high aging population, accounting for around 20%, which drives demand for medical procedures. Collaboration between healthcare providers and technology companies is fostering innovation and improving patient outcomes.

Asia-Pacific

Asia-Pacific is emerging as a rapidly growing region in the image-guided therapy systems market, accounting for approximately 23% of the global market. The region is characterized by expanding healthcare infrastructure and increasing adoption of advanced technologies. More than 5 million procedures are performed annually using image-guided systems, reflecting growing demand. Countries such as China and India are investing heavily in healthcare development, improving access to medical services. The adoption of portable imaging systems is particularly high, supporting healthcare delivery in rural areas. The region’s large population base and increasing prevalence of chronic diseases drive demand for advanced medical technologies. Government initiatives and private investments are further supporting market growth. As healthcare systems continue to develop, Asia-Pacific is expected to play a key role in the global market.

Middle East & Africa

The Middle East & Africa region holds a smaller share of the global market, accounting for approximately 10%. However, the region is experiencing steady growth due to increasing healthcare investments and infrastructure development. More than 2 million procedures annually are performed using image-guided systems, reflecting rising adoption. Governments are investing in healthcare modernization, improving access to advanced medical technologies. The prevalence of chronic diseases is increasing, driving demand for diagnostic and therapeutic solutions. The region also benefits from international collaborations and technology transfer initiatives. As healthcare systems continue to improve, the adoption of image-guided therapy systems is expected to increase steadily.

List of Top Image-guided Therapy Systems Companies

• Philips Healthcare
• Siemens Healthineers
• GE Healthcare
• Fujifilm Holdings Corporation

Top Two Companies by Market Share

• Siemens Healthineers holds approximately 21% share with over 120,000 installed systems globally and strong presence in 70 countries.
• GE Healthcare accounts for around 19% share with more than 4 million imaging procedures supported annually through its systems.

Investment Analysis and Opportunities

The image-guided therapy systems market is attracting significant investments due to increasing demand for precision-based healthcare solutions. Global healthcare infrastructure investments have increased by 36%, with a substantial portion allocated to advanced imaging technologies. Approximately 42% of hospitals plan to upgrade their imaging systems within the next three years, indicating strong investment potential. Private sector investments account for 29% of funding in imaging technologies, while government initiatives contribute 33%. Emerging markets present significant opportunities, with healthcare spending increasing by 31% in Asia-Pacific and 27% in the Middle East. AI-based imaging solutions have received 18% of total investment, reflecting growing interest in automation and predictive analytics. Collaborations between technology providers and healthcare institutions have increased by 24%, driving innovation and system integration.

New Product Development

New product development in the image-guided therapy systems market focuses on enhancing imaging accuracy and workflow efficiency. AI-enabled imaging systems have improved diagnostic precision by 33%, while real-time 3D imaging technologies provide visualization accuracy within 0.4 mm. Approximately 41% of new product launches include AI integration, enabling automated image analysis and decision support. Portable imaging devices are a key innovation area, with 29% of new products designed for mobility and ease of use. Hybrid imaging systems combining CT, MRI, and PET technologies account for 36% of recent developments, improving multi-modal imaging capabilities. Radiation dose reduction technologies have advanced, reducing exposure by 28% while maintaining image quality. Robotic-assisted imaging systems have also seen growth, with 18% of new products incorporating robotic navigation. Cloud-based imaging platforms, adopted by 31% of healthcare providers, enable remote diagnostics and data sharing.

Five Recent Developments (2023-2025)

• In 2023, a major manufacturer launched an AI-integrated CT system improving diagnostic accuracy by 35% and reducing scan time by 22%.
• In 2024, a hybrid PET-MRI system was introduced, increasing imaging precision by 31% and enabling dual-modality diagnostics.
• In 2024, a portable ultrasound device was released, reducing system weight by 28% and increasing adoption in remote healthcare settings by 26%.
• In 2025, a robotic-assisted imaging platform was developed, improving surgical precision by 37% and reducing procedure time by 19%.
• In 2025, a cloud-based imaging software solution was launched, enabling 33% faster data processing and remote access for 29% of healthcare providers.

Report Coverage of Image-guided Therapy Systems Market

The report covers a comprehensive analysis of the image-guided therapy systems market, including detailed segmentation by type and application. It examines over 7 major imaging modalities and 6 key application areas, providing insights into their respective market shares and usage patterns. The study includes data from more than 50 countries, representing over 90% of global healthcare infrastructure. The report evaluates technological advancements, including AI integration, which has reached 44% adoption, and robotic-assisted systems with 18% penetration. It analyzes regional trends, highlighting North America’s 39% share and Asia-Pacific’s rapid growth at 23%. The study also covers over 30 key market players, assessing their product portfolios and innovation strategies. Additionally, the report includes analysis of investment trends, with healthcare infrastructure spending increasing by 36%, and identifies key growth opportunities in emerging markets.